IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TABELLINI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.923
AS - Asia 3.271
EU - Europa 3.215
SA - Sud America 592
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 57
OC - Oceania 18
Totale 14.274
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.744
CN - Cina 1.403
PL - Polonia 949
SG - Singapore 895
UA - Ucraina 562
BR - Brasile 500
FR - Francia 412
IT - Italia 377
HK - Hong Kong 285
DE - Germania 262
VN - Vietnam 211
FI - Finlandia 178
GB - Regno Unito 142
IN - India 122
RU - Federazione Russa 105
CA - Canada 104
TR - Turchia 104
IE - Irlanda 91
BD - Bangladesh 73
SE - Svezia 46
AR - Argentina 36
KR - Corea 26
ID - Indonesia 22
IQ - Iraq 19
ZA - Sudafrica 19
AU - Australia 18
MX - Messico 18
NL - Olanda 18
SA - Arabia Saudita 17
JP - Giappone 14
EC - Ecuador 13
AT - Austria 12
BE - Belgio 12
ES - Italia 12
CO - Colombia 11
NG - Nigeria 11
VE - Venezuela 10
CR - Costa Rica 9
JM - Giamaica 9
CZ - Repubblica Ceca 8
HN - Honduras 8
PK - Pakistan 8
CL - Cile 7
EG - Egitto 7
IR - Iran 7
LT - Lituania 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
EU - Europa 6
MA - Marocco 6
PE - Perù 6
PH - Filippine 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
GT - Guatemala 5
KZ - Kazakistan 5
MY - Malesia 5
NI - Nicaragua 5
OM - Oman 5
SV - El Salvador 5
CH - Svizzera 4
IL - Israele 4
LB - Libano 4
MU - Mauritius 4
PR - Porto Rico 4
DZ - Algeria 3
EE - Estonia 3
JO - Giordania 3
LV - Lettonia 3
TN - Tunisia 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
IM - Isola di Man 2
KE - Kenya 2
KG - Kirghizistan 2
MN - Mongolia 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MK - Macedonia 1
RS - Serbia 1
SI - Slovenia 1
Totale 14.083
Salva come PNG Salva come JPEG
Città #
Warsaw 947
Fairfield 722
Ashburn 638
Woodbridge 552
Singapore 469
Houston 437
Shenzhen 408
Jacksonville 397
San Jose 359
Hong Kong 282
Cambridge 275
Seattle 272
Wilmington 267
Ann Arbor 245
Beijing 236
The Dalles 186
New York 171
Council Bluffs 170
Princeton 169
Brescia 157
Chandler 133
Nanjing 118
Los Angeles 99
Helsinki 93
Dublin 87
Dearborn 79
Lauterbourg 75
Istanbul 71
Nanchang 69
Columbus 66
Ho Chi Minh City 63
São Paulo 61
Dallas 54
Moscow 51
Shenyang 46
Phoenix 43
Buffalo 42
Milan 42
San Diego 40
Des Moines 39
Santa Clara 39
Chicago 37
Hanoi 37
Changsha 36
Munich 36
San Francisco 36
Hebei 32
Jinan 31
Montreal 29
London 28
Tianjin 27
Toronto 27
Redondo Beach 26
Dong Ket 24
Jiaxing 22
Shanghai 22
Orem 21
Ningbo 20
Taizhou 20
Seongnam 19
Atlanta 18
Denver 18
Chennai 15
Jakarta 15
North Bergen 15
Rio de Janeiro 15
Kunming 14
Turku 14
Zhengzhou 14
Brasília 13
Indianapolis 13
Kocaeli 13
Tokyo 13
Verona 13
Augusta 12
Brooklyn 12
Charlotte 12
Abuja 11
Riyadh 11
Haiphong 10
Hangzhou 10
Brussels 9
Johannesburg 9
Mexico City 9
Stockholm 9
Amsterdam 8
Baghdad 8
Campinas 8
Da Nang 8
Haikou 8
Lancaster 8
Mumbai 8
Nuremberg 8
Rome 8
Sydney 8
Boardman 7
Bologna 7
Boston 7
Frankfurt am Main 7
Manchester 7
Totale 9.731
Salva come PNG Salva come JPEG
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 589
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 417
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 397
NFKB1 regulates human NK cell maturation and effector functions 353
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 344
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 311
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 303
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 281
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 238
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 231
A threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. 224
CTLA-4 regulates human Natural Killer cell effector functions 220
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 219
The RAC2-PI3K axis regulates human NK cell maturation and function 216
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. 206
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 202
Inherited DOCK2 deficiency in patients with early-onset invasive infections 195
Effects of opioid therapy on human natural killer cells. 194
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. 186
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 165
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 163
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 160
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 159
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 158
Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways 157
Rab3A and Rab3D control the total granule number and the fraction of granules docked at the plasma membrane in PC12 cells 157
The emerging multiple roles of nuclear Akt 157
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 156
Re-examination of the mechanisms regulating nuclear inositol lipid metabolism. 155
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 154
Flow cytometric detection of total and serine 473 phosphorylated Akt. 153
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 152
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 147
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. 146
Nuclear changes in necrotic HL-60 cells. 146
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study 144
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 144
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 144
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 144
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 143
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. 143
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 143
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix. 142
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. 142
Localization of the small monomeric GTPases Rab3D and Rab3A in the AtT-20 rat pituitary cell line. 141
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 140
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 140
Nuclear lipids: new functions for old molecules? 139
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation 139
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 139
Nuclear apoptotic changes: an overview 136
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 135
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 135
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 131
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway. 130
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy. 129
Further considerations on the intranuclear distribution of HMGI/Y proteins. 127
Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study 126
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 125
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 124
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 121
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 120
P85α is an intrinsic regulator of human natural killer cell effector functions 119
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 118
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 118
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. 118
The controversial nuclear matrix: a balanced point of view. 116
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 113
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. 112
Phosphoinositide-specific phospholipase Cbeta1 expression is not linked to nerve growth factor-induced differentiation, cell survival or cell cycle control in PC12 rat pheocromocytoma cells. 112
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. 112
FGF-trapping hampers cancer stem-like cells in uveal melanoma 111
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1 111
Natural killer cell impairment in ovarian clear cell carcinoma 108
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by {alpha}-actinin. 105
Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. 104
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. 104
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. 103
Nuclear expression of diacylgycerol kinases: possibile involvement in DNA replication 103
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 102
Molecular characterization of protein kinase C-alpha binding to lamin A. 100
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 100
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 99
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 99
Insulin-like growth factor-I-dependent stimulation of nuclear phospholipase C-beta1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase. 95
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 92
Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party 81
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 46
Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas 44
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 38
Role of heparin-binding mediators in the resistance to anti-VEGF therapies in diabetic retinopathy 14
Totale 14.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022587 0 0 0 56 15 32 38 50 34 97 66 199
2022/2023519 125 1 3 31 33 146 5 52 59 1 28 35
2023/20241.004 36 11 462 27 17 130 32 25 163 2 8 91
2024/20251.405 11 3 6 184 155 110 119 48 158 113 332 166
2025/20263.166 269 395 260 515 306 178 411 160 199 258 135 80
2026/20271.093 203 172 276 442 0 0 0 0 0 0 0 0
Totale 14.274